24 January 1994 00:00 [Source: ICB]
The new manufacturing facility of Beijing Ciba-Geigy Pharma (BCGP), a joint venture of Ciba with the Chinese partners Beijing General Pharmaceutical Corp and Beijing No 3 Pharmaceutical factory, has officially opened. The plant, with an annual capacity for some 1bn tablets or capsules and involving an investment of over SF30m ($20.4m), will produce medicines for the treatment of diseases of the central nervous system. BCGP will open regional offices in Wuhan, Shenyang, Chonggin and Harbin over coming months, in addition to existing ones in Shanghai, Guangzhou and Tianjin.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|
Asian Chemical Connections